Rozlytrek Access Solutions
OpenVerified·Mar 20, 2026
- Covers
- financial assistance
- Enrollment cycle
- rolling
Eligibility
Patients must be prescribed ROZLYTREK (entrectinib) and submit a completed Patient Consent Form to access insurance coverage support and financial assistance options. The program is intended for U.S. residents seeking help with Genentech medicine access.
Status source
Ready to Enroll? Fill out the Patient Consent Form and send it to ROZLYTREK Access Solutions to get started.